Overview
Chung-liang Chien practices practicing medicine in Taiwan.
Their clinical expertise encompasses Glioma, Gliomatosis Cerebri, and COVID-19.
They are actively involved in clinical research, co-authoring 48 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Chung-liang Y. Chien
Is Chung-liang Y. Chien a top-rated expert for Glioma?
MediFind is an objective health platform that identifies experts based on real-world data. Chung-liang Y. Chien is classified as an Experienced expert for Glioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Chung-liang Y. Chien participate in research or clinical trials?
Yes. Chung-liang Y. Chien has published 48 articles and abstracts on conditions like Glioma. You can view a list of Chung-liang Y. Chien's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- COVID-19Chien isExperienced. Learn about COVID-19.
- GliomaChien isExperienced. Learn about Glioma.
- Gliomatosis CerebriChien isExperienced. Learn about Gliomatosis Cerebri.